(Q42987340)

12 November 2017

Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. (English)

1 reference

12 November 2017

1 reference

Mousa DH

1

1 reference

12 November 2017

Abdalla AH

2

1 reference

12 November 2017

Al-Shoail G

3

1 reference

12 November 2017

Al-Sulaiman MH

4

1 reference

12 November 2017

Al-Hawas FA

5

1 reference

12 November 2017

Al-Khader AA

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Transplantation Proceedings

12 November 2017

1 reference

12 November 2017

36

1 reference

12 November 2017

6

1 reference

12 November 2017

1831-1834

1 reference

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Hepatitis C in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Impact of hepatitis B and C virus on kidney transplantation outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Treatment of chronic hepatitis C in special groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Interferon-alpha in chronic hepatitis C infection in dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Hepatitis C virus transmission in the hemodialysis community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

Hepatitis C virus infection in dialysis and renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.025

10.1016/J.TRANSPROCEED.2004.07.025

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6mlbwxvprfe3negof55wtbyr5a

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_6mlbwxvprfe3negof55wtbyr5a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6mlbwxvprfe3negof55wtbyr5a

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/6mlbwxvprfe3negof55wtbyr5a